CDER Drug Safety Labeling Changes - 4/1/2021

Drug Safety-related Labeling Changes (SrLC) The SLC database has been updated with the following approved drug safety labeling changes. Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated CABENUVA KIT CABOTEGRAVIR; RILPIVIRINE 212888 NDA 03/29/2022 03/31/2022 EDURANT RILPIVIRINE HYDROCHLORIDE 202022 NDA 03/29/2022 03/31/2022 PLEGRIDY PEGINTERFERON BETA-1A 125499 BLA 03/29/2022 03/31/2022 POTELIGEO MOGAMULIZUMAB-KPKC 761051 BLA 03/30/2022 03/31/2022 VOCABRIA CABOTEGRAVIR SODIUM 212887 NDA 03/29/2022 03/31/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA